MAR 13, 2018 03:54 AM PDT
Directly Reversing the Effects of Common Anticoagulants
WRITTEN BY: Kara Marker
4 12 670

For people at a high risk of developing blood clots, a prescription for a type of drug called an anticoagulant is vital. But with a particular type of anticoagulant called Factor Xa inhibitors, excessive bleeding is also a risk. Scientists from McMaster University in Canada now introduce andexanet, an experimental drug that, if approved by the FDA, could be the first drug available to treat excessive bleeding for Factor Xa inhibitor patients.

A scanning electron micrograph depicted a number of red blood cells found clotted together.

Experts estimate that almost three million people in the United States currently take Factor Xa inhibitors, often older people who are at high risk for stroke and venous thrombosis due to heart failure or other problems. Anticoagulants like Factor Xa inhibitors reduce the body’s ability to form a blood clot, which is good for preventing stroke but bad in cases of uncontrolled bleeding. Andexanet’s role would come into play when patients taking Factor Xa inhibitors experience major bleeding, as the drug can directly counter the effects of the anticoagulant.

About 84,000 people taking Factor Xa inhibitors are hospitalized for major bleeding each year, often due to brain bleeding, a fall, or gastrointestinal bleeding. A quarter of all people taking Factor Xa inhibitors die when bleeding in the brain occurs. Andexanet could be the reversal agent responsible for preventing those deaths.

"Factor Xa inhibitors are already widely used because of their excellent efficacy and safety profile. However, some physicians and patients may choose to use other anticoagulant drugs because they have a reversal agent rather than using one of the Factor Xa inhibitors,” explained lead author Stuart Connolly, MD. “Having a safe and effective reversal agent available will benefit patients with acute bleeding."

Andexanet works by allowing Factor Xa, a blood coagulation factor, do its job: clot the blood. In preliminary studies with healthy patients, researchers showed that andexanet successfully reversed the anti-clotting effect of Factor Xa inhibitors, with no significant negative side effects.

Now researchers are working on a clinical trial called AMNEXA-4, recruiting patients having trouble with major bleeding as a result of taking Factor Xa inhibitors. Researchers are testing the drug for both safety and effectiveness, and so far the drug appears to be working well.

"This study is only focused on patients who are acutely bleeding, but there is also great interest in using a drug like andexanet for patients who come into a medical center on a Factor Xa inhibitor and require urgent surgery," Connolly said. "We hope to study that patient population in the future."

Sources: American College of Cardiology, Vascular Health and Risk Management, Expert Opinion on Therapeutic Targets

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 22, 2018
Cardiology
JAN 22, 2018
Decades of Research to Restore Blood Flow to the Brain
What used to be a devastating event can now be treated or even prevented. With techniques to manage strokes and the blood clots responsible for causing the
MAR 03, 2018
Immunology
MAR 03, 2018
How does inflammatory bowel disease increase heart attack risk?
Having inflammatory bowel disease (IBD) may need to be considered a risk factor for heart disease independent of classic risk factors like high blood press
MAR 17, 2018
Cardiology
MAR 17, 2018
Detecting Atrial Fibrillation On the Go
A new smartphone application can detect stroke-causing atrial fibrillation (AF) using the same accelerometer technology that counts your steps. From the Un
APR 10, 2018
Cardiology
APR 10, 2018
Genetic Risk of Heart Disease Countered by Exercise
People at a high risk for heart disease thanks to a genetic predisposition can still benefit from regular physical activity, a new study finds. Scientists
APR 23, 2018
Cardiology
APR 23, 2018
Damaged Heart Cells Can Regenerate Using Innovative Technique
There is no definitive “treatment” for the damage that results from a heart attack because the heart cells cannot regenerate themselves after s
APR 26, 2018
Cardiology
APR 26, 2018
New Gene Linked to Human Aortic Aneurysms
Using a web tool called GeneMatcher, scientists from Baylor College of Medicine studying defective copies of the ari-1 gene were matched up with scientists
Loading Comments...